A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

3.3K views

⸱

DOI:

10.3791/63060

⸱

November 5th, 2021

 ,  ,  , 

In This Article

Summary

Here, we describe a noninvasive monitoring method involving luciferase and green fluorescent protein expression in various breast cancer cell lines. This protocol provides a technique to monitor tumor formation and metastatic colonization in real time in mice.

Abstract

Breast cancer is a frequent heterogeneous malignancy and the second leading cause of mortality in women, mainly due to distant organ metastasis. Several animal models have been generated, including the widely used orthotopic mouse models, where cancer cells are injected into the mammary fat pad. However, these models cannot help monitor tumor growth kinetics and metastatic colonization. Cutting-edge tools to monitor cancer cells in real time in mice will significantly advance the understanding of tumor biology.

Here, breast cancer cell lines stably expressing luciferase and green fluorescent protein (GFP) were established. Specifically, this technique contains two sequential steps initiated by measuring the luciferase activity in vitro and followed by the implantation of the cancer cells into mammary fat pads of nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice. After the injection, both the tumor growth and metastatic colonization are monitored in real time by the noninvasive bioluminescence imaging system. Then, the quantification of GFP-expressing metastases in the lungs will be examined by fluorescence microscopy to validate the observed bioluminescence results. This sophisticated system combining luciferase and fluorescence-based detection tools evaluates cancer metastasis in vivo, which has great potential for use in breast cancer therapeutics and disease management.

Introduction

Breast cancers are frequent types of cancer worldwide, with approximately 250,000 new cases diagnosed each year in the United States1. Despite its high incidence, a new set of anticancer drugs has significantly improved breast cancer patient outcomes2. However, these treatments are still inadequate, as many patients experience disease relapse and metastatic spread to vital organs2, which is the primary cause of patient morbidity and mortality. Therefore, one of the main challenges in breast cancer research is identifying the molecular mechanisms regulating the formation of distal metastases to dev....

Access restricted. Please log in or start a trial to view this content.

Protocol

All mouse experiments were carried out under the Hebrew University Institutional Animal Care and Use Committee-approved protocol MD-21-16429-5. In addition, the Hebrew University is certified by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).

1. Cell line maintenance

NOTE: The human breast cancer cell lines (MCF-7, MDA-MB-468, and MDA-MB-231) were used in this protocol.

  1. Culture all the breast cancer cell lines in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37 °C in a humidi....

Access restricted. Please log in or start a trial to view this content.

Results

We generated breast cancer cell lines (MDA-MB-231, MCF-7, and MDA-MB-468) expressing GFP and luciferase vectors. Specifically, this was achieved by a sequential infection. First, the breast cancer cell lines were infected with a lentivirus vector expressing fluorescent GFP. The GFP-positive cells (GFP+) were sorted 2 days post-infection (Figure 1A,B) and infected with the pLX304 Luciferase-V5 vector. Then, blasticidin was used to select for luciferase to generate .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Animal-based experiments are obligatory for cancer research7,8,9, and indeed many protocols have been developed3,6,10,11,12,13,14. However, most of these studies determined the biological effect onl.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

All authors have disclosed that they do not have any conflicts of interest.

Acknowledgements

We thank the members of the Y.D.S. laboratory. We would like to thank The Wohl Institute for Translational Medicine at the Hadassah Medical Center, Jerusalem, for providing the small animal imaging facility. This study was supported by Research Career Development Award from the Israel Cancer Research Fund.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1.7 mL eppendorf tubesLifegeneLMCT1.7B-500
10 µL tipsLifegeneLRT10
1000 µL tipsLifegeneLRT1000
15 mL tubesLifegeneLTB15-500
200 µL tipsLifegeneLRT200
6 well cell culture plateCOSTAR3516
96 well Plates BLACK flat bottomBar NaorBN30496
Automated Cell CountersThermofisherA50298
BD FACSAria III sorterBD
BD Microlance 3 Needles 27 G (3/4'')BD302200
BD Plastipak Syringes 1 mL x 120BD303172
Corning 100 mm x 20 mm Style DishCORNING430167
Corning 150 mm x 20 mm Style DishCORNING430599
Countess cell counting chamber slidesThermofisherC10228
Dulbecco's modified Eagle's medium (DMEM), high glucose, no glutamineBiological Industries01-055-1A
Eclipse 80i microscopeNikon
eppendorf Centrifuge 5810 RSigma AldrichEP5820740000
Fetal Bovine Serum (FBS)Biological Industries04-127-1A
FUW GFPGifted from Dr. Yossi Buganim's lab (Hebrew University of Jerusalem)
HEK293TGifted from Dr. Lior Nissim's lab (Hebrew University of Jerusalem)
Isoflurane, USP TerrellPiramalNDC 66794-01-25
IVIS Spectrum In Vivo Imaging SystemPerkin Elmer124262
L-Glutamine SolutionBiological industries03-020-1A
Living Image SoftwarePerkinElmerbioluminescence measurement
MCF-7ATCCATCC HTB-22
MDA-MB-231ATCCATCC HTB-26
MDA-MB-468ATCCATCC HTB-132
Pasteur pipettesNORMAX2430-475
PBSHylabsBP655/500D
pCMV-dR8.2-dvprAddgene#8455Provided by David M. Sabatini’s lab (Whitehead institute, Boston, USA)
pCMV-VSV-GAddgene#8454Provided by David M. Sabatini’s lab (Whitehead institute, Boston, USA)
Penicillin-Streptomycin SolutionBiological Industries03-031-1B
Petri dish 90 mm (90x15)MINI PLAST820-090-01-017
Pipettes 10mlLifegeneLG-GSP010010S
Pipettes 25mlLifegeneLG-GSP010050S
Pipettes 5mlLifegeneLG-GSP010005S
pLX304 Luciferase-V5 blast plasmidAddgene#98580
PolybreneSigma Aldrich#107689
Prism 9GraphPad
Reagent ReservoirsBar NaorBN20621STR200TC
SMZ18 Stereo microscopesNikon
Sodium ChlorideBio-Lab190359400
Syringe filtersLifegeneLG-FPV403030S
Trypan Blue 0.5% solutionBiological industries03-102-1B
Trypsin EDTA Solution B (0.25%), EDTA (0.05%)Biological Industries03-052-1a
Vacuum driven FiltersSOFRA LIFE SCIENCESPE-22-500
Virusolvedisinfectant
VivoGlo Luciferin, In Vivo GradePromegaP1043
X-tremeGENE HP DNA Transfection ReagentSigma Aldrich#6366236001

References

  1. Waks, A. G., Winer, E. P. Breast cancer treatment: A review. JAMA. 321 (3), 288-300 (2019).
  2. Jin, X., Mu, P. Targeting breast cancer metastasis. Breast Cancer: Basic and Clinical Research. 9, Suppl 1 23-34 (2015).
  3. Saha, D., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Breast Cancer MetastasisBioluminescence ImagingTumor Growth KineticsOrthotopic Mouse ModelGFP ExpressionLuciferase ActivityLung Metastasis DetectionFluorescence MicroscopyMammary Fat Pad InjectionImmunohistochemistry Staining